These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 81545)

  • 21. Preparation of red cells coated with C4 and C3 subcomponents and production of anti-C4d and anti-C3d.
    Freedman J; Mollison PL
    Vox Sang; 1976 Oct; 31(4):241-57. PubMed ID: 822586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The quantification of C3 fragments on erythrocytes: estimation of C3 fragments on normal cells, acquired haemolytic anaemia cases and correlation with agglutination of sensitized cells.
    Merry AH; Thomson EE; Rawlinson VI; Stratton F
    Clin Lab Haematol; 1983; 5(4):387-97. PubMed ID: 6607814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serologic comparison of a monoclonal anti-C3d with commercial antiglobulin reagents.
    Barker JM
    Transfusion; 1982; 22(6):507-10. PubMed ID: 6983162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C3d antiglobulin haemagglutination of human red blood cells. A demonstration of two types of cell-bound C3d by means of typsin digestion.
    Hsu TC; Steinberg J; Sawitsky A
    J Clin Pathol; 1979 Oct; 32(10):1009-13. PubMed ID: 521493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chido, Rodgers and C4. In vivo and in vitro coating of red blood cells, grouping and antibody detection.
    Nordhagen R; Heier Larsen AM; Beckers D
    Vox Sang; 1979; 37(3):170-8. PubMed ID: 91269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of time, temperature and coagulation on the measurement of C3, C3 split products and C4.
    Sinosich MJ; Teisner B; Brandslund I; Fisher M; Grudzinskas JG
    J Immunol Methods; 1982 Nov; 55(1):107-14. PubMed ID: 6818279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of the third component of complement on stored red cells.
    Szymanski IO; Swanton RE; Odgren PR
    Transfusion; 1984; 24(3):194-7. PubMed ID: 6729934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simplified method for the preparation of EAC14.
    Matre R; Tönder O; Wesenberg F
    J Immunol Methods; 1980; 39(1-2):25-9. PubMed ID: 7007511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An enzyme-linked immunosorbent assay for the detection of complement components on red blood cells.
    Sirois M; Chartier C; Brun G; Hamel Y; Petitclerc C; Delage JM
    Am J Clin Pathol; 1984 Jul; 82(1):67-73. PubMed ID: 6377872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the third component of human complement (C3) bound to stored preserved erythrocytes and their viability in vivo.
    Szymanski IO; Odgren PR; Valeri CR
    Vox Sang; 1985; 49(1):34-41. PubMed ID: 4013142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation and fragmentation of the third (C3) and the fourth (C4) components of complement: generation and isolation of physiologically relevant fragments C3c and C4c.
    Janatova J; Gobel RJ
    J Immunol Methods; 1985 Dec; 85(1):17-26. PubMed ID: 4078308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducible in vitro preparation of intermediate C3d coated red blood cells.
    Hoffman NL; Monroe MC; Chaplin H
    Transfusion; 1982; 22(3):180-4. PubMed ID: 7046159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid method for the production of erythrocytes in the state "EC4" and "EC43".
    Jenkins DE; Moore WH; Luthringer DG; Johnson RM
    Transfusion; 1975; 15(5):402-7. PubMed ID: 812218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human serum induced opsonization of immunoglobulin G-coated polystyrene microspheres with complement components C3 and C4 as measured by flow cytometry.
    Spycher MO; Spycher-Burger M; Späth PJ; Burckhardt JJ
    J Immunol Methods; 1991 Dec; 145(1-2):83-92. PubMed ID: 1765669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative quality control of antiglobulin reagents.
    Gardner B; Ghosh S; Brazier DM; Holburn AM
    Clin Lab Haematol; 1983; 5(2):215-29. PubMed ID: 6603958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
    Spitzer RE; Stitzel AE; Pauling VL; Davis NC; West CD
    J Exp Med; 1971 Sep; 134(3 Pt 1):656-80. PubMed ID: 15776568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red cell destruction in vivo by low concentrations of IgG anti-A.
    Romano EL; Mollison PL
    Br J Haematol; 1975 Jan; 29(1):121-7. PubMed ID: 811239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.